Introduction to moderate sedation

Procedural Burden Pain and/or Fear and/or Anticipatory Anxiety

Pre-medication Emergency MRI, CT scans Fibroscopy, Endoscopy Dental

  • Needles
  • Catheters
  • Gas mask
  • Surgery

  • Fractures
  • Sutures
  • Burns

  • Claustrophic
  • Unmoving conditions

  • Fearful conditions
  • Unpleasant procedures

  • Needles
  • Drills
  • Stressful procedures

The formulation was developed at the Amiens Hospital in France, with the help of an Anaesthesiologist and a Hospital Pharmacist.

Innovation – OZALIN® / OZASED®

Launch OZALIN®*as an oral paediatric sedative licensed and approved in EU.

  • Launching in 2020-2022 across EU.
  • Utilising a mix or Primex own teams and partners across EU.
  • Expand with the submission of regulatory files for international markets.
  • Smpc
*OZALIN®  / OZASED® is indicated in infants (from 6 months), children and adolescents, for moderate sedation before a therapeutic or diagnostic procedure to relieve anxiety, distress and agitation related to the procedure or as premedication before anaesthesia. 

(Supported by an unrestricted educational grant from Primex Pharmaceuticals) is a non-profit initiative of leading paediatric anaesthesiologists. We promote safe conduct of anaesthesia in children.
(Supported by an educational grant from Primex Pharmaceuticals)

A standardized quality improvement tool from the International Committee for the Advancement of Procedural Sedation.